| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
54,818,000 |
| Market
Cap: |
131.56(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.94 - $23.76 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Outset Medical is a medical technology company, engaged in developing technology to reduce the cost and difficulty of dialysis. Co.'s Tablo® Hemodialysis System is designed for use from the hospital to the home. Tablo is a single enterprise solution for hemodialysis, comprised of a console with water purification, dialysate production and software and connectivity capabilities. Co. designed Tablo to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo can be used across multiple care settings and a range of clinical applications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
7,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$133,800 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
22,022 |
96,342 |
234,210 |
626,597 |
| Total Sell Value |
$74,511 |
$744,431 |
$3,504,253 |
$13,026,975 |
| Total People Sold |
6 |
7 |
7 |
8 |
| Total Sell Transactions |
8 |
28 |
55 |
114 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Trigg Leslie |
Chair and CEO |
• • – |
2023-08-01 |
4 |
OE |
$4.11 |
$82,200 |
D/D |
20,000 |
429,489 |
|
- |
|
| Ahmed Nabeel |
Chief Financial Officer |
• – – |
2023-08-01 |
4 |
AS |
$20.07 |
$19,869 |
D/D |
(990) |
90,736 |
|
-72% |
|
| Nash Marc |
VP Manufacturing |
• – – |
2023-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
6,338 |
45,533 |
|
- |
|
| Brottem John L. |
General Counsel |
• – – |
2023-07-19 |
4 |
AS |
$20.00 |
$28,300 |
D/D |
(1,415) |
58,945 |
|
-73% |
|
| Brottem John L. |
General Counsel |
• – – |
2023-07-19 |
4 |
OE |
$9.48 |
$13,414 |
D/D |
1,415 |
60,360 |
|
- |
|
| Nash Marc |
SVP, Operations and R&D |
• – – |
2023-07-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,195 |
|
-75% |
|
| Ahmed Nabeel |
Chief Financial Officer |
• – – |
2023-07-03 |
4 |
AS |
$21.70 |
$21,483 |
D/D |
(990) |
91,726 |
|
-82% |
|
| Trigg Leslie |
Chair and CEO |
• • – |
2023-07-03 |
4 |
AS |
$20.90 |
$417,944 |
D/D |
(20,000) |
409,489 |
|
-82% |
|
| Trigg Leslie |
Chair and CEO |
• • – |
2023-07-03 |
4 |
OE |
$4.11 |
$82,200 |
D/D |
20,000 |
429,489 |
|
- |
|
| Brottem John L. |
General Counsel |
• – – |
2023-06-20 |
4 |
AS |
$21.97 |
$31,066 |
D/D |
(1,414) |
58,945 |
|
-85% |
|
| Brottem John L. |
General Counsel |
• – – |
2023-06-20 |
4 |
OE |
$9.48 |
$13,405 |
D/D |
1,414 |
60,359 |
|
- |
|
| Ahmed Nabeel |
Chief Financial Officer |
• – – |
2023-06-01 |
4 |
AS |
$20.83 |
$20,622 |
D/D |
(990) |
92,716 |
|
-56% |
|
| Trigg Leslie |
Chair and CEO |
• • – |
2023-06-01 |
4 |
AS |
$21.10 |
$421,920 |
D/D |
(20,000) |
409,489 |
|
-56% |
|
| Trigg Leslie |
Chair and CEO |
• • – |
2023-06-01 |
4 |
OE |
$4.11 |
$82,200 |
D/D |
20,000 |
429,489 |
|
- |
|
| Drexler Karen |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,681 |
23,232 |
|
- |
|
| Szyman Catherine M |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,681 |
24,596 |
|
- |
|
| Grossman D Keith |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,681 |
17,849 |
|
- |
|
| Jones Dale E |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,681 |
20,918 |
|
- |
|
| Saia Andrea Lynn |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,681 |
22,892 |
|
- |
|
| Hackett Patrick T |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,681 |
17,849 |
|
- |
|
| Hinrichs James F. |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,681 |
55,349 |
|
- |
|
| Brottem John L. |
General Counsel |
• – – |
2023-05-17 |
4 |
AS |
$20.08 |
$54,859 |
D/D |
(2,732) |
58,945 |
|
-46% |
|
| Brottem John L. |
General Counsel |
• – – |
2023-05-17 |
4 |
OE |
$9.48 |
$13,414 |
D/D |
1,415 |
61,677 |
|
- |
|
| Brottem John L. |
General Counsel |
• – – |
2023-05-16 |
4 |
AS |
$19.91 |
$26,580 |
D/D |
(1,335) |
60,262 |
|
-45% |
|
| Racine Jean-Olivier |
Chief Technology Officer |
• – – |
2023-05-16 |
4 |
S |
$19.91 |
$14,634 |
D/D |
(735) |
79,227 |
|
45% |
|
347 Records found
|
|
Page 3 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.02 (0.84%) 
